All of the available data support that GOF mutations in PTPN11 play a causal role in NS, LS, and JMML; however, whether the contribution of PTPN11 mutations to acute leukemias represents a primary event or a second hit acquired during disease progression is not conclusive. Here, PTPN11 is linked to acute leukemia.